Cargando…

Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022

Reports of tecovirimat-resistant mpox have emerged after widespread use of antiviral therapy during the 2022 mpox outbreak. Optimal management of patients with persistent infection with or without suspected resistance is yet to be established. We report a successfully treated case of severe mpox in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Contag, Caitlin A., Mische, Leah, Fong, Isabel, Karan, Abraar, Vaidya, Akanksha, McCormick, David W., Bower, William, Hacker, Jill K., Johnson, Kelly, SanJuan, Perla, Crebbin, Linda, Temmins, Caroline, Sahni, Harleen, Bogler, Yael, Cooper, Joseph D., Narasimhan, Supriya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683816/ https://www.ncbi.nlm.nih.gov/pubmed/37856215 http://dx.doi.org/10.3201/eid2912.230849

Ejemplares similares

Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Tecovirimat Resistance in Mpox Patients, United States, 2022–2023
por: Smith, Todd G., et al.
Publicado: (2023)

2684. Characteristics of mpox patients treated with Tecovirimat: a single center review
por: Vargas, Robert, et al.
Publicado: (2023)

Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat
por: Hernandez, Loren E, et al.
Publicado: (2022)

1790. Characteristics of Patients with Mpox Treated with Tecovirimat during the 2022 Outbreak in Puerto Rico
por: Gonzalez, Hector J Melendez, et al.
Publicado: (2023)

Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
por: Ouyang, Megan, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System
por: Vo, Christopher, et al.
Publicado: (2023)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
por: Lash, Maura K., et al.
Publicado: (2023)

Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022)

Prevalence of Mpox (Monkeypox) in patients undergoing STI screening in northern California, April-September 2022
por: Contag, Caitlin A., et al.
Publicado: (2023)

Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022)

Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report
por: Martinez, Andres E., et al.
Publicado: (2023)

Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public–private hospital partnership during the 2022 NYC mpox outbreak
por: Mgbako, Ofole, et al.
Publicado: (2023)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Monkeypox Proctitis: A Case of Targeted Treatment With Tecovirimat
por: Patel, Premalkumar, et al.
Publicado: (2023)

Tecovirimat for Monkeypox in the Central African Republic under Expanded Access
por: Mbrenga, Festus, et al.
Publicado: (2022)

Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge()()
por: Russo, Andrew T., et al.
Publicado: (2020)

Le técovirimat dans le traitement de la variole simienne
por: Halani, Sheliza, et al.
Publicado: (2023)

In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat
por: Nunes, Desiree dos Santos, et al.
Publicado: (2023)

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
por: Matias, Wilfredo R, et al.
Publicado: (2022)

Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease
por: Beatty, Norman L., et al.
Publicado: (2022)

Myocarditis Attributable to Monkeypox Virus Infection in 2 Patients, United States, 2022
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals
por: Feng, Yumiao, et al.
Publicado: (2021)

Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023)

893. Myocarditis and Pericarditis as a Complication of Mpox: An International Case Series and Literature Review
por: Halani, Sheliza, et al.
Publicado: (2023)

Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays
por: Mills, Margaret G., et al.
Publicado: (2023)

A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
por: Almehmadi, Mazen, et al.
Publicado: (2022)

Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
por: Chen, Zhang-Ren, et al.
Publicado: (2022)

Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
por: Mondi, Annalisa, et al.
Publicado: (2023)

Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023)

Ebola and the need for restructuring pharmaceutical incentives
por: Karan, Abraar, et al.
Publicado: (2015)

Does the Stockholm Syndrome affect female sex workers? The case for a “Sonagachi Syndrome”
por: Karan, Abraar, et al.
Publicado: (2018)

Mpox-associated myopericarditis
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2023)

Viroporins of Mpox Virus
por: Basu, Kingshuk, et al.
Publicado: (2023)

Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
por: Russo, Andrew T, et al.
Publicado: (2018)

Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
por: Perzia, Brittany, et al.
Publicado: (2022)

Retrospective Screening of Clinical Samples for Monkeypox Virus DNA, California, USA, 2022
por: Contag, Caitlin A., et al.
Publicado: (2023)

2674. Disparities in Mpox Care: Use of the Social Vulnerability Index to Predict Mpox Infections
por: Leonard, Michael, et al.
Publicado: (2023)

A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome
por: Viguier, Clément, et al.
Publicado: (2022)

14. Monkeypox viral detection from different body sites. Northern California, June–July 2022
por: Srinivasan, Krithika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m3rmqmkl5u29qih7d922g54569